Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making
Francesco Pavese, Ettore Capoluongo, Margherita Muratore, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4571-4571
Open Access | Times Cited: 17

Showing 17 citing articles:

Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers
Petra ter Brugge, Sarah C. Moser, Ivan Bièche, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Homologous Recombination Defects and Mutations in DNA Damage Response (DDR) Genes BesidesBRCA1andBRCA2as Breast Cancer Biomarkers for PARP Inhibitors and Other DDR Targeting Therapies
Ioannis A. Voutsadakis, Athina Stravodimou
Anticancer Research (2023) Vol. 43, Iss. 3, pp. 967-981
Open Access | Times Cited: 18
Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
Mariia Ivanova, Carlo Pescia, Dario Trapani, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1981-1981
Open Access | Times Cited: 5
Unmet need for previously untreated metastatic triple-negative breast cancer: a real-world study of patients diagnosed from 2011 to 2022 in the United States
Kevin Punie, Allison W. Kurian, Ιωάννα Ντάλλα, et al.
The Oncologist (2025) Vol. 30, Iss. 3
Open Access
Clinical Outcomes and Predictors of Pathological Response in Triple Negative Breast Cancer Patients Receiving Anthracycline/Taxane-Based Neoadjuvant Therapy
Mehmet Sabri Çiftçi, Burak Uçaner, Mehmet Zeki Buldanlı, et al.
Indian Journal of Surgery (2025)
Closed Access
Monensin Inhibits Triple-Negative Breast Cancer in Mice by a Na+-Dependent Cytotoxic Action Unrelated to Cytostatic Effects
Simone Fiorilla, F Tasso, Nausicaa Clemente, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 185-185
Open Access
A comprehensive review on targeted therapies for triple negative breast cancer: an evidence-based treatment guideline
Hosny I. Emara, Nageh K. Allam, R.A. Youness
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy
Raz Mutai, Iryna Kuchuk, Alexandra Goldshtein, et al.
Breast Cancer Research and Treatment (2024)
Open Access | Times Cited: 2
Present and Future of Immunotherapy for Triple-Negative Breast Cancer
Sushmitha Sriramulu, Shivani Thoidingjam, Corey Speers, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3250-3250
Open Access | Times Cited: 2
Local Treatment of Triple-Negative Breast Cancer: Is Mastectomy Superior to Breast-Conserving Surgery?
Alba Di Leone, Antonio Franco, Francesca Zotta, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 865-865
Open Access | Times Cited: 5
Survival Outcomes and Efficacy of Platinum in Early Breast Cancer Patients with Germline BRCA1 or BRCA2 Mutation: A Multicenter Retrospective Cohort Study
Xi Chen, Xiaoyan Qian, Min Xiao, et al.
Breast Cancer Targets and Therapy (2023) Vol. Volume 15, pp. 671-682
Open Access | Times Cited: 4
Nitro-fatty acids: promising agents for the development of new cancer therapeutics
Jessica Roos, Georg Manolikakes, Uwe Schlomann, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 11, pp. 1061-1080
Open Access | Times Cited: 1
DNA Mismatch Repair System Imbalances in Breast Adenocarcinoma
G. Metaxas, Evangelos Tsiambas, Spyridon S Marinopoulos, et al.
Cancer Diagnosis & Prognosis (2023) Vol. 3, Iss. 2, pp. 169-174
Open Access | Times Cited: 2
Retrospective Observational Study to Determine the Epidemiology and Treatment Patterns of Patients with Triple-Negative Breast Cancer
Magdalena Rosińska, Roman Dubiański, Aleksandra Konieczna, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1087-1087
Open Access
Neoadjuvant chemotherapy vs upfront surgery for resectable locally advanced oral squamous cell carcinoma: A retrospective single center study
Xiaotong He, Xiaoyue Lei, Yangxi Cheng, et al.
Advances in Clinical and Experimental Medicine (2024) Vol. 34, Iss. 10
Open Access
Breast Cancer Associated Conventional and Advanced Therapies 
Kirti Amresh Gautam, Nimisha Singh, Priyanka Tyagi, et al.
International Journal of Pharmaceutical and Phytopharmacological Research (2023) Vol. 13, Iss. 3, pp. 22-37
Open Access | Times Cited: 1
Erken Evre Triple Negatif Meme Kanserinde Sağkalım Sonuçları ve Prognostik Faktörler: Tek Merkez Deneyimi
Yasin Kutlu, Sabin Göktaş Aydın, Ahmet Bılıcı, et al.
Uludağ Üniversitesi Tıp Fakültesi Dergisi (2023) Vol. 49, Iss. 3, pp. 355-360
Open Access
The Impact of Germline BRCA Mutations in Locally Advanced, Triple Negative Breast Cancer Treated with Platinum Based Neoadjuvant Chemotherapy
Raz Mutai, Iryna Kuchuk, Alexandra Goldshtein, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top